SYN-COLL

Skin, Hair & CosmeticCosmetic

Theoretically sound approach based on known collagen biology, but lacks published clinical validation. The concept is scientifically reasonable, though independent evidence for its effectiveness remains absent.

Cosmetic chemists and dermatological researchers focusing on topical anti-aging interventions study this peptide.

FDA Status
Research Only

Since Feb 2026

Evidence
Limited data
Studies

0 total

What is SYN-COLL?

This synthetic tripeptide was designed to trigger the body's natural collagen production pathways by essentially fooling cells into thinking they've received a specific biological signal. Cosmetics researchers developed it as a way to address age-related collagen loss without relying on topical collagen itself, which doesn't penetrate skin effectively. The peptide appears primarily in anti-aging skincare formulations targeting fine lines and skin firmness.

The peptide works by impersonating a key portion of thrombospondin-1, a protein that normally tells cells to start producing collagen. When skin cells encounter this molecular mimic, they activate TGF-beta, a growth factor that kicks off the cellular machinery responsible for manufacturing both type I and type III collagen. Think of it as a chemical messenger that delivers a 'build more structural support' instruction to the skin's repair crews.

Reported Benefits

Collagen stimulation
Wrinkle depth reduction
Skin elasticity
TGF-beta activation

Regulatory Status

Research OnlyEffective: Feb 2026

Last verified: Feb 2026

Related Peptides

This information is for research purposes only and does not constitute medical advice. Always consult a licensed physician before using any peptides.